Nicolas Lecrenier

579 total citations
18 papers, 400 citations indexed

About

Nicolas Lecrenier is a scholar working on Epidemiology, Parasitology and Dermatology. According to data from OpenAlex, Nicolas Lecrenier has authored 18 papers receiving a total of 400 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Epidemiology, 7 papers in Parasitology and 5 papers in Dermatology. Recurrent topics in Nicolas Lecrenier's work include Herpesvirus Infections and Treatments (15 papers), Bartonella species infections research (5 papers) and Acne and Rosacea Treatments and Effects (4 papers). Nicolas Lecrenier is often cited by papers focused on Herpesvirus Infections and Treatments (15 papers), Bartonella species infections research (5 papers) and Acne and Rosacea Treatments and Effects (4 papers). Nicolas Lecrenier collaborates with scholars based in Belgium, United States and Australia. Nicolas Lecrenier's co-authors include Pierre van der Bruggen, Françoise Foury, Raunak Parikh, Desmond Curran, Amit Bhavsar, Javier Díez‐Domingo, Elisa Cisneros, Raffael Nachbagauer, Ariana Hirsh and Édith Beaulieu and has published in prestigious journals such as Annals of Oncology, Gene and Clinical Journal of Pain.

In The Last Decade

Nicolas Lecrenier

18 papers receiving 392 citations

Peers

Nicolas Lecrenier

EPIDE

DERMA

IMMUN

PARAS

Phillip Sung United States

Jennifer Kintner United States

Christopher D. Petro United States

Gini van Rijckevorsel Netherlands

Erin P. Ribka United States

Hussain Badani United States

Vikas Peddu United States

D G Tedder United States

Phillip Sung United States

Nicolas Lecrenier

246 ×0.9

EPIDE

73 ×0.8

18 ×0.3

DERMA

158 ×2.4

IMMUN

37 ×0.6

PARAS

Citations per year, relative to Nicolas Lecrenier Nicolas Lecrenier (= 1×) peers Phillip Sung

Countries citing papers authored by Nicolas Lecrenier

Since Specialization

Citations

This map shows the geographic impact of Nicolas Lecrenier's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nicolas Lecrenier with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nicolas Lecrenier more than expected).

Fields of papers citing papers by Nicolas Lecrenier

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nicolas Lecrenier. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nicolas Lecrenier. The network helps show where Nicolas Lecrenier may publish in the future.

Co-authorship network of co-authors of Nicolas Lecrenier

This figure shows the co-authorship network connecting the top 25 collaborators of Nicolas Lecrenier. A scholar is included among the top collaborators of Nicolas Lecrenier based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nicolas Lecrenier. Nicolas Lecrenier is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

18 of 18 papers shown

Bhavsar, Amit, et al.. (2024). Systematic Literature Review on the Incidence of Herpes Zoster in Populations at Increased Risk of Disease in the EU/EEA, Switzerland, and the UK. Infectious Diseases and Therapy. 13(5). 1083–1104. 5 indexed citations

Bhavsar, Amit, et al.. (2023). 1761P Incidence of herpes zoster in cancer patients in Europe: A systematic review. Annals of Oncology. 34. S951–S951. 1 indexed citations

Curran, Desmond, T. Mark Doherty, Nicolas Lecrenier, & Thomas Breuer. (2023). Healthy ageing: Herpes zoster infection and the role of zoster vaccination. npj Vaccines. 8(1). 184–184. 20 indexed citations

Ramasubramanian, V, et al.. (2023). Proceedings of the expert consensus group meeting on herpes zoster disease burden and prevention in India: An opinion paper. Human Vaccines & Immunotherapeutics. 19(2). 2220608–2220608. 1 indexed citations

Matthews, Sean, Desmond Curran, Céline Boutry, et al.. (2023). An Analysis of How Herpes Zoster Pain Affects Health-related Quality of Life of Placebo Patients From 3 Randomized Phase III Studies. Clinical Journal of Pain. 39(8). 386–393. 3 indexed citations

Mwakingwe-Omari, Agnes, et al.. (2023). Recombinant zoster vaccine in immunocompetent and immunocompromised adults: A review of clinical studies. Human Vaccines & Immunotherapeutics. 19(3). 2278362–2278362. 21 indexed citations

Curran, Desmond, et al.. (2022). Modeled impact of the COVID-19 pandemic and associated reduction in adult vaccinations on herpes zoster in the United States. Human Vaccines & Immunotherapeutics. 18(1). 2027196–2027196. 6 indexed citations

Curran, Desmond, Sean Matthews, Céline Boutry, et al.. (2022). Natural History of Herpes Zoster in the Placebo Groups of Three Randomized Phase III Clinical Trials. Infectious Diseases and Therapy. 11(6). 2265–2277. 6 indexed citations

Parikh, Raunak, et al.. (2022). An update on national recommendations for the use of the adjuvanted recombinant zoster vaccine. European Journal of Public Health. 32(Supplement_3). 2 indexed citations

10.

Friedland, Leonard R., et al.. (2022). BPI22-019: Guidelines and Recommendations for the Adjuvanted Recombinant Zoster Vaccine in Immunocompromised Cancer Patients. Journal of the National Comprehensive Cancer Network. 20(3.5). BPI22–19. 2 indexed citations

11.

Díez‐Domingo, Javier, et al.. (2021). Correction to: Can COVID-19 Increase the Risk of Herpes Zoster? A Narrative Review. Dermatology and Therapy. 11(4). 1127–1128. 1 indexed citations

12.

Díez‐Domingo, Javier, et al.. (2021). Can COVID-19 Increase the Risk of Herpes Zoster? A Narrative Review. Dermatology and Therapy. 11(4). 1119–1126. 54 indexed citations

13.

Parikh, Raunak, et al.. (2021). A practitioner’s guide to the recombinant zoster vaccine: review of national vaccination recommendations. Expert Review of Vaccines. 20(9). 1065–1075. 28 indexed citations

14.

Silva, Fernanda Tavares Da, et al.. (2021). An Analysis of Spontaneously Reported Data of Vesicular and Bullous Cutaneous Eruptions Occurring Following Vaccination with the Adjuvanted Recombinant Zoster Vaccine. Drug Safety. 44(12). 1341–1353. 8 indexed citations

15.

Lecrenier, Nicolas, et al.. (2020). Ten years of experience with the pneumococcal non-typeableHaemophilus influenzaeprotein D-conjugate vaccine (Synflorix) in children. Expert Review of Vaccines. 19(3). 247–265. 14 indexed citations

16.

Lecrenier, Nicolas, Rómulo E. Colindres, Desmond Curran, et al.. (2018). Development of adjuvanted recombinant zoster vaccine and its implications for shingles prevention. Expert Review of Vaccines. 17(7). 619–634. 76 indexed citations

17.

Nachbagauer, Raffael, Angela Choi, Ariana Hirsh, et al.. (2016). A chimeric haemagglutinin-based influenza split virion vaccine adjuvanted with AS03 induces protective stalk-reactive antibodies in mice. npj Vaccines. 1(1). 77 indexed citations

18.

Lecrenier, Nicolas, Pierre van der Bruggen, & Françoise Foury. (1997). Mitochondrial DNA polymerases from yeast to man: a new family of polymerases. Gene. 185(1). 147–152. 75 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact